PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
11.79%
Revenue growth below 50% of CRON.TO's 23.88%. Michael Burry would check for competitive disadvantage risks.
73.20%
Cost growth 50-75% of CRON.TO's 101.66%. Bruce Berkowitz would examine sustainable cost advantages.
-46.43%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-52.08%
Both companies show margin pressure. Martin Whitman would check industry conditions.
88.66%
R&D growth above 1.5x CRON.TO's 1.90%. Michael Burry would check for spending discipline.
27.85%
G&A growth above 1.5x CRON.TO's 2.36%. Michael Burry would check for operational inefficiency.
-3.10%
Marketing expense reduction while CRON.TO shows 28.82% growth. Joel Greenblatt would examine competitive risk.
-2087.13%
Other expenses reduction while CRON.TO shows 160.62% growth. Joel Greenblatt would examine efficiency.
17.64%
Operating expenses growth above 1.5x CRON.TO's 9.72%. Michael Burry would check for inefficiency.
49.74%
Total costs growth 1.25-1.5x CRON.TO's 35.26%. Martin Whitman would scrutinize control.
-14.42%
Interest expense reduction while CRON.TO shows 16.67% growth. Joel Greenblatt would examine advantage.
11.96%
D&A growth less than half of CRON.TO's 65.20%. David Dodd would verify if efficiency is sustainable.
11.92%
EBITDA growth while CRON.TO declines. John Neff would investigate advantages.
-295.55%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-309.91%
Both companies show declining income. Martin Whitman would check industry conditions.
-287.78%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-369.08%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-3600.20%
Pre-tax income decline while CRON.TO shows 135.48% growth. Joel Greenblatt would examine position.
-3210.05%
Pre-tax margin decline while CRON.TO shows 128.64% growth. Joel Greenblatt would examine position.
-1523.43%
Both companies reducing tax expense. Martin Whitman would check patterns.
-2284.85%
Net income decline while CRON.TO shows 135.37% growth. Joel Greenblatt would examine position.
-2033.39%
Net margin decline while CRON.TO shows 128.55% growth. Joel Greenblatt would examine position.
-2260.25%
EPS decline while CRON.TO shows 134.09% growth. Joel Greenblatt would examine position.
-2260.25%
Diluted EPS decline while CRON.TO shows 134.09% growth. Joel Greenblatt would examine position.
0.61%
Share count reduction exceeding 1.5x CRON.TO's 2.40%. David Dodd would verify capital allocation.
0.61%
Diluted share reduction exceeding 1.5x CRON.TO's 2.40%. David Dodd would verify capital allocation.